{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 408591350
| IUPAC_name = ''N''-(4-methoxybenzyl)-''N<nowiki>'</nowiki>'',''N<nowiki>'</nowiki>''-dimethyl-''N''-pyridin-2-ylethane-1,2-diamine
| image = Mepyramine.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|mepyramine}}
| MedlinePlus = a606008
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 91-84-9
| CAS_supplemental = <br/>{{CAS|59-33-6}} (maleate)
| ATC_prefix = R06
| ATC_suffix = AC01
| ATC_supplemental =  {{ATC|D04|AA02}}
| PubChem = 4992
| IUPHAR_ligand = 1227
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB06691
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4818
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = HPE317O9TL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08183
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 6762
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 511
<!--Chemical data-->
| C=17 | H=23 | N=3 | O=1
| molecular_weight = 285.38 g/mol
| smiles = O(c1ccc(cc1)CN(c2ncccc2)CCN(C)C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = YECBIJXISLIIDS-UHFFFAOYSA-N
| synonyms = <small>''N''-[2-(dimethylamino)ethyl]-''N''-[(4-methoxyphenyl)methyl]pyridin-2-amine</small>
}}
'''Mepyramine''', also known as '''pyrilamine''', is a [[Antihistamine#H1-receptor antagonists|first generation antihistamine]], targeting the [[Histamine H1 receptor|H<sub>1</sub> receptor]].<ref>{{cite journal | last1 = Parsons | first1 = Mike E. | last2 = Ganellin |first2 = C. Robin | title = Histamine and its receptors | journal = British Journal of Pharmacology | volume = 147 | pages = S127–S135 |date=January 2006 | pmid = 16402096 | doi = 10.1038/sj.bjp.0706440 | pmc = 1760721 | issue = S1}}</ref> However, it rapidly permeates the brain often causing [[drowsiness]]. It also has [[anticholinergic]] properties. It is used in over-the-counter combination products to treat the common cold and menstrual symptoms.<ref>[http://midol.com/menstrual_complete_caps.html#q1 Active Ingredients for Midol Complete]</ref> It is also the active ingredient of the topical antihistamine creams ''Anthisan'' and ''Neoantergan'', sold for the treatment of insect bites, stings, and nettle rash.
==Synthesis==
[[File:Pyrilamine synthesis.png|thumb|center|700px|Pyrilamine synthesis:<ref>R.J. Horclois, {{US Patent|2502151}} (1950).</ref><ref>{{Cite journal | last1 = Huttrer | first1 = C. P. | last2 = Djerassi | first2 = C. | last3 = Beears | first3 = W. L. | last4 = Mayer | first4 = R. L. | last5 = Scholz | first5 = C. R. | title = Heterocyclic amines with antithistaminic activity | journal = Journal of the American Chemical Society | volume = 68 | issue = 10 | pages = 1999–2002 | year = 1946 | doi = 10.1021/ja01214a037 | pmid =  
21001124| pmc = }}</ref><ref>D. Bovet, R. Horclois, F. Walthert, C.R. Soc. Biol., 138, 99 (1944).</ref>]]

==See also==
* [[Chloropyramine]] (chloro instead of methoxy)

== References ==
{{Reflist}}

{{Antipruritics}}
{{Antihistamines}}
{{Hallucinogens}}
{{Navboxes
| title = [[Pharmacodynamics]]
| titlestyle = background:#ccccff
| list1 = 
{{Histamine receptor modulators}}
{{Monoamine reuptake inhibitors}}
{{Muscarinic acetylcholine receptor modulators}}
{{Sigma receptor modulators}}
}}

[[Category:Amines]]
[[Category:Aromatic amines]]
[[Category:H1 receptor antagonists]]
[[Category:Muscarinic antagonists]]
[[Category:Phenol ethers]]
[[Category:Pyridines]]
[[Category:Sigma receptor ligands]]


{{respiratory-system-drug-stub}}
{{dermatologic-drug-stub}}